Biopure moves to sell blood substitute in Europe.
Burton
Thomas M
TM
D001802:Blood Substitutes / Q000009:adverse effects* / Q000191:economics; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008389:Marketing of Health Services; D020521:Stroke / Q000209:etiology; D014481:United States; D014486:United States Food and Drug Administration
D001802:Blood Substitutes